CTLA4 and neoplasm: Among ICIs, the representative (PDCD1,PD-1) inhibitor, its (CD274,PD-L1) inhibitor, and cytotoxic T-lymphocyte associated protein 4 (CTLA4) restore the ability of immune cells to fight tumors by counteracting the inhibition of the immune system by tumor cells.